
AMICULUM is an independent family of 11 branded agencies that delivers communications and consultancy services to pharmaceutical, biotechnology and health technology companies across the world.
Continue reading “AMICULUM”AMICULUM is an independent family of 11 branded agencies that delivers communications and consultancy services to pharmaceutical, biotechnology and health technology companies across the world.
Continue reading “AMICULUM”Featuring AMICULUM, Ashfield MedComms, Fishawack Health, Helios Medical Communications and Oxford PharmaGenesis. Recorded as a MedComms Networking webinar. Produced by NetworkPharma.tv
Continue reading “In conversation with the medical writers”Featuring AMICULUM. Recorded as a MedComms Networking webinar. Produced by NetworkPharma.tv
Continue reading “Building an agency fit for the future: the importance of culture and core values”From first learning about genetics in GCSE science lessons, I knew that it was a subject that I wanted to pursue. Fast forward several years and I had gained a degree and PhD in genetics and had a productive period of post-doc research under my belt. However, it was then decision time. Did I want to stay in academia, or did I want to branch out into something new?
Having stumbled into doing a PhD almost by accident as part of my research assistant role at Imperial College London, I had never really intended to pursue a career in academia. However, I soon found myself loving the lab with a flair for growing parasites and a taste for diligent documentation. I couldn’t believe that I was getting paid to play in a lab all day long – I had found my happy place. So, when the good times ground to a halt, and my endeavours in the lab were failing, and the politics and diplomacy of seeking funding began to weigh heavily, I was in all honesty devastated at the prospect of leaving the lab. A friend of mine had moved on to MedComms not long before me with favourable reports, so I took the leap as well. I thought that it would be a tough adjustment, but I truly have not once missed the lab, and have instead found a new passion for MedComms.